Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event. The technology recreates […]
It’s an all-too-common story within cancer care: a patient enters remission, only to discover a few months later that their tumour has returned. Just as bacterial infections can become resistant to antibiotics, cancer cells can […]
Alzheimer’s disease research has taken another hit with the termination of a Phase III study assessing the effect of diabetes drug pioglitazone on mild cognitive impairment (MCI) in patients with the condition. Takeda and Zinfandel […]
Netherlands-based Synthon Biopharmaceuticals has obtained fast-track designation from the US Food and Drug Administration (FDA) for its investigational antibody-drug conjugate (ADC) [vic-]trastuzumab duocarmazine (SYD985) to treat HER2-positive metastatic breast cancer (MBC). The approval covers patients […]
Edinburgh, Scotland based Synpromics has teamed up with UCL Great Ormond Street Institute of Child Health to develop novel gene therapies for diseases affecting the haematopoietic system. This partnership further expands the firm’s activities […]